Schrodinger, Inc. (SDGR) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Schrodinger, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.993 -- 00:00:05.258 Thank you for standing by. Welcome to Schrodinger's conference call to review first quarter 00:00:05.258 -- 00:00:11.126 2025 financial results. My name is Calvin and I will be your operator for today's call. 00:00:11.126 -- 00:00:15.211 Please be advised that this call is being recorded at the company's request. 00:00:15.211 -- 00:00:18.135 Now I would like to introduce your host for today's conference, Ms. 00:00:18.135 -- 00:00:22.260 Sharon Madden, Senior Vice President of Investor Relations and Corporate Affairs. 00:00:22.260 -- 00:00:24.601 Please go ahead. 00:00:24.601 -- 00:00:28.788 Thank you and good afternoon, everyone. Welcome to today's call during which we will 00:00:28.788 -- 00:00:33.976 provide an update on the company and review our first quarter 2025 financial results. 00:00:33.976 -- 00:00:38.023 Earlier today, we issued the press release summarizing our financial results and progress 00:00:38.023 -- 00:00:42.590 across the company, which is available on our website at schrodinger.com. 00:00:42.590 -- 00:00:47.219 Here with me on our call today are Rami Fareed, Chief Executive Officer, Jeff Porges, 00:00:47.219 -- 00:00:51.949 Chief Financial Officer, and Karen Akinsanya, President of R&D Therapeutics. 00:00:51.949 -- 00:00:55.155 Following our prepared remarks, we'll open the call for Q&A. 00:00:55.155 -- 00:00:58.682 During today's call, management will make statements that are forward-looking and made 00:00:58.682 -- 00:01:02.610 pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act 00:01:02.610 -- 00:01:07.697 of 1995 including without limitation statements related to our financial outlook for 00:01:07.697 -- 00:01:12.783 the full year 2025 and the second quarter 2025, our pla...